MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: AllgemeineskmqacaAntwortenAntworten: kmqaca <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 14:54 Uhr</div>[url=https://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/]Zoya Demidenko[/url]: Scholar in Cancer Studies [url=https://www.instagram.com/zoyamonros/]Zoya Demidenko[/url] is a notable investigator affiliated with the Department of Cell Stress Biology at Roswell Park Cancer Institute in Buffalo, New York. Before that, she was employed at the NIH and New York Medical College, building a strong background in biomedical study. Demidenko's scientific work spans multiple pivotal domains, including the PI3K/AKT/mTOR signaling pathway, cell cycle management, cell senescence, and tumor science. As of now, she has written more than 46 peer-reviewed articles, which have garnered over 4,100 references — a testament to the influence of her research. Among her most notable achievements involves explaining the pathways of cell aging. Her work showed that when the cellular division cycle is arrested yet cellular growth persists, cells experience senescence. Importantly, [url=https://www.facebook.com/public/Zoya-Demidenko/]Zoya Demidenko[/url] showed that this shift is pharmacologically suppressed using compounds such as mTOR inhibitors. [url=https://www.benthamdirect.com/content/journals/cpd/22/16]Zoya Demidenko[/url] has also contributed considerably to cancer treatment investigation, especially in the field of cyclotherapy — a approach designed to protecting healthy tissue from anticancer drugs while leaving cancer cells vulnerable. This approach offers significant promise for lowering the adverse effects of oncological therapy. Throughout her scientific life, Demidenko has collaborated with top investigators globally, such as Dr. Mikhail Blagosklonny. Her research is published in top-tier journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. [31.03.2026 11:21] Папа: With an h-index of 33, [url=https://aacrjournals.org/cancerres/article/64/10/3653/511273/Flavopiridol-Induces-p53-via-Initial-Inhibition-of?guestAccessKey=]Zoya Demidenko[/url] stands as a widely cited contributor in current biomedical research, whose findings keep to guide our comprehension of the way cells grow old, respond to therapy, and how malignant disease can be more effectively targeted. https://www.researchgate.net/scientific-contributions/Zoya-N-Demidenko-39445053</blockquote><br> Abbrechen
